Precision Biosciences (DTIL) Interest Coverage Ratio Growth (3y) (2021 - 2026)
Precision Biosciences (DTIL) Interest Coverage Ratio Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn | 28.11% |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 40.09% |
| 10 | Precision Biosciences | 182.42 Mn | 154.13 Mn | - | 7.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.99% |
| Dec 31, 2025 | 60.61% |
| Sep 30, 2025 | 54.68% |
| Jun 30, 2025 | -50.63% |
| Mar 31, 2025 | -127.73% |
| Dec 31, 2024 | 46.18% |
| Sep 30, 2024 | -25.31% |
| Jun 30, 2024 | -38.85% |
| Mar 31, 2024 | 36.27% |
| Dec 31, 2023 | 10.41% |
| Sep 30, 2023 | -65.73% |
| Jun 30, 2023 | 67.02% |
| Mar 31, 2023 | -32.15% |
| Sep 30, 2022 | -50.82% |
| Jun 30, 2022 | 10.68% |
| Mar 31, 2022 | 9.44% |
| Dec 31, 2021 | -124.97% |